Aldeyra Reports Lower Itching, Discomfort For Reproxalap Vs Xiidra In Dry Eye Patients

Aldeyra Therapeutics, Inc. (ALDX) announced positive data from a Phase 2 clinical trial comparing ocular discomfort and itching symptom scores of reproxalap ophthalmic solution 0.25%, an investigational new drug, versus Xiidra or lifitegrast ophthalmic solution 5 percent in patients with dry eye disease.

The double-masked, crossover, single-center, Phase 2 clinical trial in 56 dry eye disease patients evaluated ocular discomfort and itching and were statistically lower with reproxalap than with Xiidra.

Earlier a trial has demonstrated tolerability advantages of reproxalap over Xiidrain patients with dry eye disease.

The company said the combination of rapid activity and improved tolerability evidenced by reproxalap will help address compliance issues with currently available therapy.

Peter Couroux, Global Senior Medical Director for Cliantha Research and the principal investigator of the clinical trial noted that if approved, reproxalap has the potential to become a first-line therapy for the treatment of dry eye disease.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration is looking to set a new framework to further improve and maintain the supply of infant formula to ensure that American consumers have access to safe and nutritious infant formula. Infant formula is an essential food product that is the sole source of nutrition for many babies in the U.S. Amazon has unveiled millions of deals worldwide that will be available during its upcoming Prime Day extravaganza. The 48-hour shopping event for Prime members kicks off July 12 at 3 a.m. EDT, offering deals of up to 79% off across various categories. These include electronics, devices, toys, beauty, fashion, and home, from top national brands and small businesses. Primal Pet Foods is recalling a single lot of Raw Frozen Primal Patties for Dogs Beef Formula due to potential contamination with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves lot #W10068709 of 6-pound Raw Frozen Primal Patties with best by date of 05/22/23. The Raw Frozen Primal Patties are sold in flexible packaging in the freezer at select pet stores.
Follow RTT